APA (7th ed.) Citation

L, D., M, R., F, M., Y, H., JM, B., G, M., & SM, A. (2017). Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and pro-inflammatory cytokines in multiple sclerosis patients. European journal of pharmacology, 811, 148. https://doi.org/10.1016/j.ejphar.2017.06.017

Chicago Style (17th ed.) Citation

L, Delgado-Roche, Riera-Romo M, Mesta F, Hernández-Matos Y, Barrios JM, Martínez-Sánchez G, and Al-Dalaien SM. "Medical Ozone Promotes Nrf2 Phosphorylation Reducing Oxidative Stress and Pro-inflammatory Cytokines in Multiple Sclerosis Patients." European Journal of Pharmacology 811 (2017): 148. https://doi.org/10.1016/j.ejphar.2017.06.017.

MLA (9th ed.) Citation

L, Delgado-Roche, et al. "Medical Ozone Promotes Nrf2 Phosphorylation Reducing Oxidative Stress and Pro-inflammatory Cytokines in Multiple Sclerosis Patients." European Journal of Pharmacology, vol. 811, 2017, p. 148, https://doi.org/10.1016/j.ejphar.2017.06.017.